In Vivo Cluster AI Prediction (CLAIRE) of COVID-19 Disease Progression

Project: Research project

Project Details


NARRATIVE During the current COVID-19 pandemic, it is difficult for physicians admitting new patients to the hospital to distinguish patients whose disease will be mild from those who will have a severe disease progression. While this can also occur with the seasonal flu and other infectious respiratory diseases, the degree of severity seen in COVID-19, the potential of accelerated deterioration, and the high pressure on hospital resources for extended periods of time present a compelling and urgent need to better understand and anticipate the risk factors that may drive severe disease. Lifetime Omics is developing CLAIRE, a viral cluster AI system for prediction of infectious respiratory disease progression, such as COVID-19, using metagenomics and AI to provide personalized information to inform treatment decisions, help improve outcomes, and better utilize healthcare resources.
Effective start/end date7/1/215/31/22


  • National Institute of Biomedical Imaging and Bioengineering: $248,723.00
  • National Institute of Biomedical Imaging and Bioengineering: $22,734.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.